Zimmer Historical Financial Ratios
| ZBH Stock | USD 112.15 1.51 1.36% |
Zimmer Biomet is currently reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 4.46, Dividend Yield of 0.0153, PTB Ratio of 1.63 or Days Sales Outstanding of 55.38 will help investors to properly organize and evaluate Zimmer Biomet Holdings financial condition quickly.
Zimmer |
About Zimmer Financial Ratios Analysis
Zimmer Biomet HoldingsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Zimmer Biomet investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Zimmer financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Zimmer Biomet history.
Zimmer Biomet Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Zimmer Biomet Holdings stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Zimmer Biomet sales, a figure that is much harder to manipulate than other Zimmer Biomet Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Zimmer Biomet Holdings dividend as a percentage of Zimmer Biomet stock price. Zimmer Biomet Holdings dividend yield is a measure of Zimmer Biomet stock productivity, which can be interpreted as interest rate earned on an Zimmer Biomet investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Zimmer Biomet's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Zimmer Biomet Holdings current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of now, Zimmer Biomet's EV To Sales is increasing as compared to previous years. The Zimmer Biomet's current Inventory Turnover is estimated to increase to 1.28, while PTB Ratio is projected to decrease to 1.63.
| 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.007529 | 0.00791 | 0.009136 | 0.0153 | Price To Sales Ratio | 3.85 | 3.43 | 2.79 | 4.46 |
Zimmer Biomet fundamentals Correlations
Click cells to compare fundamentals
Zimmer Biomet Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Zimmer Biomet fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 4.41 | 3.77 | 3.85 | 3.43 | 2.79 | 4.46 | |
| Dividend Yield | 0.006415 | 0.007784 | 0.007529 | 0.00791 | 0.009136 | 0.0153 | |
| Ptb Ratio | 2.54 | 2.03 | 2.22 | 2.04 | 1.72 | 1.63 | |
| Days Sales Outstanding | 75.48 | 67.34 | 72.66 | 71.2 | 70.38 | 55.38 | |
| Book Value Per Share | 58.93 | 60.72 | 57.38 | 59.84 | 61.43 | 64.5 | |
| Free Cash Flow Yield | 0.0351 | 0.0524 | 0.041 | 0.0474 | 0.0533 | 0.0413 | |
| Operating Cash Flow Per Share | 5.82 | 7.19 | 6.13 | 7.58 | 7.38 | 4.0 | |
| Pb Ratio | 2.54 | 2.03 | 2.22 | 2.04 | 1.72 | 1.63 | |
| Ev To Sales | 5.45 | 4.75 | 4.62 | 4.19 | 3.53 | 4.87 | |
| Free Cash Flow Per Share | 5.25 | 6.46 | 5.23 | 5.77 | 5.63 | 3.31 | |
| Roic | 0.0161 | 0.0356 | 0.0399 | 0.0626 | 0.0568 | 0.0539 | |
| Inventory Turnover | 1.01 | 0.94 | 0.87 | 0.91 | 0.98 | 1.28 | |
| Net Income Per Share | (0.66) | 1.93 | 1.1 | 4.91 | 4.45 | 4.67 | |
| Days Of Inventory On Hand | 420.29 | 399.93 | 388.08 | 417.79 | 372.35 | 263.09 | |
| Payables Turnover | 6.45 | 6.4 | 5.7 | 5.08 | 11.26 | 11.82 | |
| Research And Ddevelopement To Revenue | 0.0563 | 0.053 | 0.0638 | 0.0585 | 0.062 | 0.057 | |
| Capex To Revenue | 0.0168 | 0.0223 | 0.0271 | 0.0815 | 0.0465 | 0.0463 | |
| Cash Per Share | 3.87 | 1.89 | 1.82 | 1.99 | 2.59 | 2.75 | |
| Pocfratio | 25.69 | 17.15 | 20.8 | 16.06 | 14.31 | 20.63 | |
| Interest Coverage | 3.41 | 4.13 | 6.46 | 6.35 | 5.9 | 5.6 | |
| Pfcf Ratio | 28.48 | 19.08 | 24.37 | 21.09 | 18.78 | 25.42 | |
| Days Payables Outstanding | 56.59 | 57.07 | 64.0 | 71.92 | 32.42 | 30.79 | |
| Income Quality | (8.77) | 3.37 | 4.41 | 1.54 | 3.31 | 3.48 | |
| Roe | (0.0113) | 0.0317 | 0.0192 | 0.082 | 0.0725 | 0.0689 | |
| Ev To Operating Cash Flow | 31.77 | 21.62 | 24.94 | 19.59 | 18.1 | 22.95 | |
| Pe Ratio | (225.21) | 64.01 | 115.49 | 24.8 | 23.74 | 35.21 | |
| Ev To Free Cash Flow | 35.22 | 24.06 | 29.22 | 25.73 | 23.75 | 28.36 | |
| Earnings Yield | (0.00444) | 0.0156 | 0.008659 | 0.0403 | 0.0421 | 0.0407 | |
| Intangibles To Total Assets | 0.67 | 0.62 | 0.65 | 0.64 | 0.63 | 0.45 | |
| Net Debt To E B I T D A | 3.17 | 7.55 | 3.1 | 2.4 | 2.52 | 1.7 | |
| Current Ratio | 1.99 | 1.41 | 1.88 | 1.61 | 1.91 | 2.82 | |
| Tangible Book Value Per Share | (19.89) | (8.56) | (7.71) | (5.69) | (5.28) | (5.55) | |
| Receivables Turnover | 4.84 | 5.42 | 5.02 | 5.13 | 5.19 | 5.89 |
Currently Active Assets on Macroaxis
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.41) | Dividend Share 0.96 | Earnings Share 4.43 | Revenue Per Share | Quarterly Revenue Growth 0.043 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.